Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

 		Moderate-to-severe Plaque Psoriasis Russia NCT06142357

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

 		Relapsing Multiple Sclerosis Phase3 Argentina
Austria
Belgium
Brazil
Bulgaria
Chile
China
Colombia
Croatia
Denmark
Georgia
Guatemala
Hong Kong
India
Ireland
Israel
Italy
Jordan
Latvia
Lebanon
Lithuania
Malaysia
Mexico
Netherlands
Poland
Saudi Arabia
Slovakia
Spain
Switzerland
Taiwan
Turkey (Türkiye)
United Arab Emirates
United Kingdom
United States
View All
 NCT05147220

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

 		Plaque, Atherosclerotic Phase4 China NCT06372925

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

 		Sjögrens Disease, Systemic Lupus Erythematosus, Rheumatoid Arthritis Phase2 Argentina
Canada
Hungary
Italy
Poland
Spain
United States
View All
 NCT06293365

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

 		Asthma Phase3 Argentina
Austria
Bulgaria
Colombia
Czechia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
Vietnam
View All
 NCT05562466

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

 		Multiple Sclerosis, Relapsing-Remitting Italy NCT06345157

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

 		Fascioliasis Phase4 Colombia
Egypt
Peru
Turkey (Türkiye)
Vietnam
View All
 NCT04230148

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

 		Severe Malaria Phase2 Burkina Faso
Congo, The Democratic Republic of the
Côte D'Ivoire
Gabon
Kenya
Mozambique
Nigeria
Rwanda
Uganda
View All
 NCT04675931

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

 		Advanced Solid Tumors Which Are cMET-dependent Phase2 China
United States 		NCT03040973

Home Reported Outcomes in PNH

 		Paroxysmal Nocturnal Hemoglobinuria United States NCT06411626